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GLUCOCORTICOIDS are very effective inhibitors of both the
acute and chronic inflammatory response. In this study the
hypothesis that glucocorticoids inhibit an early compo-
nent of the inflammatory response, neutrophil adhesion to
endothelium, by down-regulation of adhesion molecules
on neutrophils or endothelium was examined. No effect
of dexamethasone on neutrophil adhesion to endothelium
or of antigen expression by neutrophils or endothelium
was found. The mechanism of action of glucocorticoids in
the inflammatory response is probably not mediated by
alterations in adhesion molecules.
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For many years glucocorticoids have been
recognized as having important anti-inflammatory
properties. A report from the 1940s testified to the
efficacy of glucocorticoids in patients with rheuma-
toid arthritis. These drugs are used clinically in
many of the acute and chronic inflammatory
conditions and in the vasculitidies.
2
Of particular recent interest is the use of
dexarnethasone in the treatment of acute inflam-
matory conditions, where host-cell directed tissue
injury, particularly neutrophil mediated, is thought
to contribute to disease morbidity and mortality.
One such condition in the paediatric population is
bacterial meningitis,3’4 with the majority of North
American pediatric infectious disease program
directors utilizing glucocorticoid therapy in the
treatment of acute bacterial sepsis and meningitis,
Dexamethasone is also recommended for use in
preterm infants at risk of developing broncho-
pulmonary dysplasia.
6 However, in another condi-
tion where neutrophils are considered to induce
pulmonary pathology, Adult Respiratory Distress
Syndrome (ARDS), glucocorticoids have no
discernible benefit.
7 The reasons for this lack of
effect are unclear, and illustrate that in spite of such
widespread acceptance of glucocorticoid therapy,
understanding the mode of action of these
anti-inflammatory agents has been slow.
Glucocorticoids are thought to modulate neu-
trophil-endothelial cell interactions, a key area in
the acute inflammatory response. It has been
observed that following in vivo administration of
glucocorticoids, there is a moderate neutrophilia
within 4-6 h.8 Mechanisms of this are unclear, but
are thought to include delayed bone marrow release
and intravascular retention.
8 Continued administra-
tion of glucocorticoids induces a progressive rise in
peripheral blood neutrophil counts until day 7,
followed by a steady fall to baseline levels.
9
As glucocorticoids inhibit the inflammatory
response, and neutrophil adhesion to endothelium
is an early component of the inflammatory response,
in this paper the hypothesis that glucocorticoids
inhibit neutrophil adhesion to endothelium (thereby
inducing a neutrophilia in a manner analogous to
that found in patients with leukocyte adhesion
deficiency) by down-regulating adhesion molecules
on neutrophils or endothelium is examined.
Abbreviations: LPS, lipopolysaccharide; NBCS, newborn calf serum; FMLP,
Phe-Met-Leu-Phe; MHC, major histocompatibility complex; ICAM-1, inter-
cellular adhesion molecule ELAM-1, endothelial leukocyte adhesion molecule
1; IL-1, interleukin 1; IL-2, interleukin 2; TNF, turnout necrosis factor; LTB4,
leukotriene B4.
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Methods
Endothelial culture: Endothelial cells were obtained
from human umbilical cords collected daily from a
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maternity hospital. From the time of delivery until
endothelium cell harvest, the cords were stored in
sterile RPMI 1640 (Gibco) containing 80 U/ml
gentamicin (David Bull Laboratories). Endothelial
cells were harvested by digestion of the veins for
15 min at 37C with collagenase type II (Sigma, C
6885, St Louis) 0.1% reconstituted in Dulbecco’s
MEM without pyruvate with 4 500 mg/1 glucose
(Gibco 043-5630, Paisley, Scotland). The ceils were
cultured in endothelial cell growth medium
consisting of ISCOVES Cell Culture Medium
(Gibco), supplemented with 10% foetal calf serum
and 10% newborn calf serum (Flow), gentamicin
80 U/ml (David Bull Laboratories), 0.02% ampho-
tericin B (Squibb), and 2 mM glutamine. Cells were
cultured at 37C in a 5% CO2 atmosphere in 25 cm
2
tissue culture flasks (Linbro). By inversion
microscopy the extent of confluence of the cells was
assessed daily. When confluent they were passaged
by exposing the endothelial cells to 0.05% trypsin
and 0.02% EDTA in modified Puck’s saline A
(Gibco 043-5300) for 3 min at 37C, followed by
washing and re-seeding into new culture flasks.
Endothelial cells were used at the second to third
passage. Before use, endothelial cells were trans-
ferred to Linbro 96-well tissue culture grade
microtitre plates for assessment of adhesion,
or to glass coverslips for endothelial antigen
expression analysis. Prior to assay the endothelial
cells were confirmed visually to be confluent by
inversion microscopy; this generally occurred 3-5
days after seeding.
Endothelial stimulants: Endothelium was stimulated
with LPS (lipopolysaccharide, Sigma, St Louis) at
100 ng/ml for 20 h prior to analysis.
Endothelial immunophenotyping Immunostaining of
cultured endothelium was performed on either
unstimulated or LPS stimulated endothelium. The
biotin-streptavidin horseradish peroxidase techni-
que was used to identify surface antigens on
endothelium--in our hands this technique is more
sensitive and specific than either ELISA or flow
cytometric estimation of endothelial antigen expres-
sion. Coverslips which were confluent with
endothelium were mounted, endothelial surface
uppermost, on to glass slides with Loctite glass glue
640. Slides were fixed in cold 100% ethanol for
10 min, and then rehydrated in decreasing con-
centrations of ethanol. To rehydrated endothelium
was added a 1:50 dilution of goat serum to block
Fc receptors. This was incubated at room
temperature for 30 min. Excess goat serum was
flicked off the coverslip, and, without washing,
100/.zl of each antibody to be tested at pre-
determined optimal dilution was pipetted onto each
coverslip and incubated at room temperature for
30 min in a moist chamber. The slides were washed
three times in Dulbecco’s phosphate buffered saline
(DPBS) with 1% NBCS followed by 100#1 of
anti-mouse IgG Biotin (Amersham), reincubated
for a further 30 min and washed in DPBS. To each
coverslip 100/21 of streptavidin horseradish perox-
idase (Amersham) was added and the reincubation
and washing procedure repeated.
The slides were then flooded for approximately
10 min with a 0.12% solution of diaminobenzidine
tetrahydrochloride (Sigma) containing 5/21 of
hydrogen peroxide (Gurr) added just prior to use,
washed three times in DPBS with NBCS, and
counterstained for 30 s with Mayer’s haematoxylin.
Slides were dehydrated in increasing concentra-
tions of ethanol and then washed in xylene. Slides
were mounted with coverslips using DePex (Gurr)
mounting medium and examined microscopically.
The pattern and intensity of staining were
assessed by two observers. A subjective scoring
system was used to objectify the particular pattern
seen. This scoring was as follows:
Negative No immunostaining present.
1 + Light immunostaining.
2 4- Moderate immunostaining involving
> 90% of cells.
3 4- Heavy immunostaining involving
> 95% of cells.
Antibodies: Endothelium was immunostained with
the antibodies listed in Table 1. Neutrophils were
immunostained for flow cytometric analysis with
the antibodies listed in Table 2. Negative control
antibodies used were Coulter Clone control
(Coulter Immunology, Florida) purified mouse IgG
(all isotypes).
Preparation of neutrophils: All care was taken
throughout the preparation stages to avoid
neutrophil activation. Venous blood from normal
adult donors (laboratory or hospital staff) was
Table 1. Antibodies directed against endothelial antigens
CD/Group Antibody Isotype Reference/
Company
MHC Class W6/32 G2a ref. 10
MHC Class II HLA-DR G2a DAKO
CD29 4B4 G1 Coulter
CD54 (ICAM-1) 6.5 B5 G ref. 11
ELAM-1 1.2 B6 G ref. 11
Cell fibronectin FN3 G ref. 12
-1 antichymotrypsin DF57 G D. Flavell,
Southampton
Anti-CD29 (4B4) recognizes the common fl chain of the fll
integrin family. ICAM-1 (CD54, antibody 6.5 B5) and ELAM-1
(antibody 1.2 B6) are adhesion molecules. Cellular fibronectin
(FN3 antibody) is an extracellular matrix adhesive protein and
a ligand for many members of the integrin family. Antibody
DF57 recognizes the anti-protease -1 antichymotrypsin,
present on endothelial cells.
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Table :;). Antibodies directed against neutrophil antigens Briefly, 100/,1 of neutrophil suspension (1.5 x
106 cells/ml) was added to confluent endothelium
CD/Group Antibody Isotype Ref./Company grown on 96-well microtitre plates (Linbro). These
MHC Class W6/32 G2a ref. 10 were incubated for 30min, washed to remove
MHC Class II HLA-DR G2a DAKO non-adherent neutrophils, and 100 #1 of buffer
CD18 MHM23 G1 DAKO (colourless RPMI +1% FCS) replaced into the
CDllb Leu 15 G2a Becton-Dickenson wells. Hence these wells contained only adherent
CD18 and CD11b are members of the f12 leukocyte integrin neutrophils. To quantitate these adherent cells, a
family, and play an important role in neutrophil adhesion to standard curve of neutrophil numbers was
endothelium, constructed by adding to unused wells 100 #1 of the
original neutrophil suspension, and in duplicate
making doubling dilutions of the original neu-
collected into preservative-free heparin or EDTA, trophil suspension. Neutrophil numbers were then
diluted with an equal volume of DPBS, and counted using an alkaline phosphatase EIA (enzyme
underlayered with Ficoll-Faque (Pharmacia, Uppsa- immunoassay).
la, Sweden). After centrifugation at 400 x g, for
20 min, the pellet containing red cells and A lkalinephosphatase EIA One hundred microlitres of
1% p-nitrophenyl phosphate disodium (Sigma, St neutrophils was isolated. Most of the red cells were
removed by sedimentation with 3% sterile dextran Louis) in diethanolamine buyer (1 M, pH 9.8) was
(Fisons, Loughborough)for 30 min. The remaining added to each well, and incubated at 37C for 3 to
4 h. The optical density of each well was measured red cells were removed by a hypotonic lysis step,
consisting of a 10 s exposure to double distilled at 405 nm in a microplate scanner (Biotek
water, followed by reconstitution in double Instruments). Adherent cell numbers were esti-
strength DPBS with 1% foetal calf serum (FCS). mated by interpolation from the standard curve.
Cells were recentrifuged at 200 x g for 5 min, Dexamethasone pre-incubation of neutrophils did
not alter alkaline phosphatase levels. counted in a haemocytometer, and reconstituted to
1-2 106 cells/ml in colourless (without phenol Flow cytometric anasis of neutrophil receptors: The
red) RPMI 1640 (Gibco, Paisley, Scotland) fluorescent intensity of neutrophils (either un-
containing 1% FCS. Neutrophils were used within stimulated or stimulated with 10-7M FMLP) 1 h. Lack of the phenol red dye in this RPMI meant incubated with the leukocyte integrin antibodies,
the pH of the solution had to be checked each time either pretreated with dexamethasone or on their
it was used. The pH was maintained between 7.3 own, was assessed by reference to the mode
and 7.5. As the optical density of the neutrophil fluorescent intensity as provided by Becton
suspension was used to quantitate the cells (vide Dickinson’s Consort 30 Program linked to a
infra), a colourless buffer was preferred. Neutrophils FACScanTM.
prepared in this way were shown morphologically
to be about 96% pure. There were approximately Role of dexamethasone" To assess the role of
4% contaminating eosinophils in this preparation, glucocorticoids on neutrophil or endothelial
as judged by a cytospin preparation using a antigen expression and adhesion, dexamethasone
modified May Grunwald stain (consisting of (David Bull Laboratories) at final concentrations of
Geimsa’s stain 6 mg, May Grunwald stain 5 mg, 0.01, 0.1 and 1 #M was tested. Differing time
methanol 4 ml, pH 6.8 buffered water 9.5 ml and periods of coincubation of dexamethasone with
30% Brij 35, 5 #1) and observed microscopically, endothelium were assessed, ranging from 30 min to
Siliconized plasticware was used at all stages of cell 24 h. In the majority of experiments assessing the
preparation, effect of dexamethasone, endothelium was pre-
treated for 6h. To assess the effect of dexa-
Neutrophil adhesion to endothelium" This was performed methasone on neutrophils, these two substances
utilizing the alkaline phosphatase method, de- were incubated together for 2h.
scribed in detail previously.
13 The principle of this
assay is that neutrophils contain endogenous Statistics" The assessment of endothelial immu-
alkaline phosphatase. If an alkaline phosphatase nophenotype was performed on six separate
substrate which changes colour by the action of occasions. Adhesion assays, done in quadruplicate,
alkaline phosphatase is added, the resultant optical were performed on five separate occasions. The
density gives an estimation of the number of flow cytometry experiments were performed on
alkaline phosphatase-containing neutrophils pre- four separate occasions. Error bars refer to
sent. If the optical density of the starting population -k I SD from the mean. Differences between
ofneutrophils is compared with that of the adherent means were compared by a t-test; significant if
cells, the percentage adherent can be estimated, p < 0.05.
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Results
Efect of dexamethasone on immunophenotype:
Eect of dexamethasone on endothelial antigen expression.
Coincubation of dexamethasone with cultured
unstimulated endothelium at doses of 0.01M to
1.0/M had no effect on the endothelial expression
of antigens tested (MHC Class I, Class II, CD29,
1CAM-l, ELAM-1, cellular fibronectin, -1 anti-
chymotrypsin). Endothelium stimulated with LPS
becomes activated, altering its antigen expression
(Table 3). Pretreatment of endothelium with
dexamethasone for 6 h prior to LPS stimulation was
unable to abrogate the activation changes induced
by LPS. After 20 h of LPS stimulation, there is
increased endothelial expression of adhesion mole-
cules ICAM-1 and ELAM-1, with a lesser increase
in MHC Class II expression. Endothelium pre-
treated with dexamethasone for 6 h prior to the
addition of LPS for a further 20h showed no
abrogation in adhesion molecule expression. In
particular dexamethasone was unable to inhibit
ELAM-1 or ICAM-1 induction by LPS.
Effect of dexamethasone on neutrophil integrin expression.
Neutrophils stimulated by FMLP increase expres-
sion of the leukocyte integrins as assessed by the
mode fluorescent intensity on flow cytometry.
Dexamethasone pretreatment of neutrophils stimu-
lated by FMLP was unable to abrogate such
changes (Table 4).
Eect ofdexamethasone on neutrophil adhesion to endothelium
Effect ofdexamethasone onneutrophiladherence to endothelium.
Dexamethasone preincubated with resting en-
dothelium for up to 24 h prior to the neutrophil
adhesion assay had no effect on baseline neutrophil
adhesion to endothelium.
Effect of dexamethasone on neutrophil adhesion to LPS
stimulated endothelium. Activation of endothelium by
Table 4. Neutrophil integrin expression and effect of dexa-
methasone
Antigen Mode Mode Mode
fluorescence fluorescence fluorescence
(resting) (post FMLP) (post dex + FMLP)
Class 336 _+ 14 346 _+ 15 307 _+ 24
Class II 8_+ 9 _+ 9 _+
CD18 702 _+ 35 746 _+ 12 741 _+ 19
CD11b 667 + 22 791 + 37 793 + 42
Mode fluorescent intensity of neutrophils for the antigens listed
either resting, after FMLP stimulation, or after dexamethasone
incubation followed by FMLP stimulation. The FMLP increases
mode fluorescent intensity of neutrophils for CD18 and
CD11 b-dexamethasone is unable to abrogate this increase.
treatment with LPS increases neutrophil adherence
to endothelium. Prior co-culture of endothelium
with dexamethasone was unable to abrogate this
increase (Fig. 1).
Effect of dexamethasone on FMLP stimulated neutrophil
adhesion to LPS stimulated endothelium. In acute
inflammatory states it is likely that both the
endothelium and circulating neutrophils are acti-
vated. In an attempt to mimic such a state, the
endothelium was incubated with LPS, with the
neutrophils added in the adhesion assay stimulated
by 10-7M FMLP. Dexamethasone pre-treatment
of the activated endothelium was unable to inhibit
the augmented adherence of neutrophils stimulated
with FMLP to endothelium stimulated with LPS
(Fig. 2).
Discussion
In this study dexamethasone was found to have
no discernible effect on both stimulated or
unstimulated neutrophil adhesion to stimulated or
Baseline
Table 3. Endothelial antigen expression
Antibody CD Expression
LPS
Unstim Post LPS 20 Post
h dexamethasone
6 h plus 20 h
W6/32 Class 3 + 3 + 3 +
HLA-DR Class II 0-1 + 2+ 2+
4B4 CD29 3+ 3+ 3+
6.5 B5 CD54 + 2+ 2+
1.2 B6 ELAM-1 0 2+ 2+
FN3 3+ 3+ 3+
DF57 3+ 3+ 3+
Expression on endothelium by immunoperoxidase staining,
either unstimulated or after LPS stimulation, of the above
antigens. Expression is given as 0-3+, depending on staining
intensity. Dexamethasone preincubation of endothelium is
unable to inhibit the LPS-induced increases in Class II, ICAM-1
and ELAM-1 expression.
LPS .01H.M Dex
LPS O. M Dex
LPS 1.0 p.M Dex
0 10 20 30 40 50 60 70
% adherence
FIG. 1. Dexamethasone effect on neutrophil adherence to LPS-stimulated
endothelium. Neutrophil adherence, either baseline, or to endothelium
stimulated for 20 h with LPS. To dexamethasone pretreated endothelium
was added LPS for 20 h, and neutrophil adherence assessed. LPS
increases neutrophil binding to endothelium. Dexamethasone at
concentrations of 0.01 to /M is unable to inhibit this augmented
adherence.
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FIG. 2. Dexarnethasone effect on activated neutrophil adherence to
activated endothelium. LP$ stimulated endothelium and FMLP stimu-
lated neutrophils induces a hyperadherent state. Dexamethasone
pretreatrnent of endotheliurn does not abrogate this adherence.
unstimulated endothelium, or on the expression of
neutrophil or endothelial adhesion molecules.
The precise mechanism of action of glucocorti-
coids is unclear. Glucocorticoids are thought to
exert their effect by inducing synthesis of
lipocortins.
14 In turn, lipocortins are considered to
inhibit phospholipase A2 production of arachidonic
acid and the eicosanoids,
is specifically by blocking
mRNA synthesis and therefore expression of group
II phospholipase A2 .16 Dexamethasone has been
reported to reduce levels of IL-1 and TNF in the
CSF of experimentally infected animals,
17 and it is
thought that glucocorticoids alter gene expression
of a number of key proteins in the inflammatory
response, for example decreasing IL-1 production.
18
Several glucocorticoid effects on neutrophils are
well documented. Dexamethasone has been re-





21 and reduce release of mediators
dependent on phospholipase A2 .22 There is evidence
that superoxide generation, and release of lacto-
ferrin and lysozyme, is reduced in neutrophils
pre-incubated for 20 min with dexamethasone.
23
Lipocortin 1 can inhibit superoxide production.
24
There is, however, a dissenting report that
dexamethasone does not inhibit neutrophil chemo-
taxis, degranulation, LTB4 production, or neu-
trophil adherence to activated endothelium (vide
infra) .25
Glucocorticoid effects on endothelial cells or the
vascular bed are poorly defined. As mentioned
above,
2s dexamethasone has been reported to be
unable to inhibit activated neutrophils adhering to
activating endothelium, although it did have a
suppressive effect on unstimulated neutrophils
adhering to unstimulated endothelium. Dex-
amethasone has been shown to decrease prostaglan-
din 12 synthesis by endothelial cells, but not to
increase lipocortin I production.
26 Dexamethasone
does not reduce arachidonic acid release from
endothelial cells,
27 or affect arachidonyl CoA
synthetase activity.
28
There seems then to be a dichotomy between the
clinical experience with glucocorticoids and the
experimental details obtained with individual
tissues in vivo. It may be that the effects of
glucocorticoids and the lipocortins act ’earlier’ or
’upstream’ of the neutrophil or endothelial cell. An
analogous example might be IL-2, which has
marked effects on the endotheliurn, although none
of these effects are direct--rather they are induced
by other mediators. It is possible for example that
glucocorticoids affect macrophage-type cells, induc-
cing a suppression of inflammatory mediators.
Glucocorticoids are a very effective therapeutic
modality. To provide therapy as effective as the
glucocorticoids without the side-effects requires an
understanding of how they operate. It is clear from
this limited study that their effects on the
inflammatory process are complex, and are not
mediated primarily through adhesion molecules.
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